Validation of a Fully Automated HER2 Staining Kit in Breast Cancer

Background: Testing for HER2 amplification and/or overexpression is currently routine practice to guide Herceptin therapy in invasive breast cancer. At present, HER2 status is most commonly assessed by immunohistochemistry (IHC). Standardization of HER2 IHC assays is of utmost clinical and economica...

Descripción completa

Detalles Bibliográficos
Autores principales: Moelans, Cathy B., Kibbelaar, Robby E., van den Heuvel, Marius C., Castigliego, Domenico, de Weger, Roel A., van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2010
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619247/
https://www.ncbi.nlm.nih.gov/pubmed/20203372
http://dx.doi.org/10.3233/CLO-2010-0514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619247/
https://www.ncbi.nlm.nih.gov/pubmed/20203372
http://dx.doi.org/10.3233/CLO-2010-0514

Ejemplares similares